Impact Factor 4.400

The 1st most cited open-access journal in Pharmacology & Pharmacy

General Commentary ARTICLE

Front. Pharmacol., 08 April 2016 | https://doi.org/10.3389/fphar.2016.00062

Expression of Concern: Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design

An expression of concern on
Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design

by Khatun, S., and Sutradhar, K. B. (2014). Front. Pharmacol. 5:137. doi: 10.3389/fphar.2014.00137

With this notice, we alert readers that Frontiers has received two messages questioning the soundness of the experimental results of the publication “Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design” published on 11 June 2014 in Frontiers in Pharmacology. Our Chief Editors, Prof. Theophile Godfraind and Dr. Dominique Dubois, will direct an investigation in full accordance with our procedures and with the collaboration of the authors. The situation will be updated as soon as the investigation is complete.

Citation: Frontiers in Pharmacology Editorial Office (2016) Expression of Concern: Water hyacinth: a possible alternative rate retarding natural polymer used in sustained release tablet design. Front. Pharmacol. 7:62. doi: 10.3389/fphar.2016.00062

Received: 25 February 2016; Accepted: 04 March 2016;
Published: 08 April 2016.

Edited and reviewed by: Dominique J. Dubois, Université Libre de Bruxelles, Belgium

Copyright © 2016 Frontiers in Pharmacology Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers in Pharmacology Editorial Office, pharmacology.editorial.office@frontiersin.org